HPS masthead
What's New?
. Fukushima Decontamination Report
. CRCPD & CDC Grants for Volunteer Corps
. America's Nuclear Future
. February Newsletter
. Boice Nominated President of NCRP
. February Journal
. February ORS
. Schauer Given the Butterfly Award from Image Gently
. Kase President's Report to IRPA
. IRPA13 Accepting Posters
Upcoming Events
. HPS Midyear - Issues in Waste Management
5-8 February 2012
Dallas, Texas
. NRC Regulatory Information Conference
NRC Regulatory Information Conference
13-15 March 2012
Rockville, Maryland
. NCRP Annual Meeting
12-13 March 2012
Washington, DC
. James E. Turner Memorial Symposium
Call for Abstracts
18-19 April 2012
Oak Ridge Associated Universities, Pollard Auditorium, Oak Ridge, Tennessee
. IRPA13
13-18 May 2012
Glasgow, Scotland
. Canadian Radiation Protection Association (CRPA) Annual Meeting
27-30 May 2012
Halifax, Nova Scotia
. ACS Undergrad Summer Schools
10 June- 20 July 2012
. Nuclear Regulatory Commission Meeting Webcasts
February 2012
Bethesda, Maryland
08 February 2012

Answer to Question #4716 Submitted to "Ask the Experts"

Category: Medical and Dental Equipment/Shielding — Shielding

The following question was answered by an expert in the appropriate field:

Q

How do I figure out the thickness of a lead syringe shield based on HVL (half-value layer) and the attenuation coefficient of lead? How do you tell how much shielding a person will get based on the amount of thickness of lead and attenuation coefficient?

A

A random review of a commercial vendor's lead and tungsten syringe shields indicates that most of the shields come in fixed thicknesses and are sized according to commercially available syringe sizes. If the vendor does not specify the thickness or lead-equivalent thickness, then you will have to contact the vendor for additional information or obtain a syringe shield and measure the thickness. The half-value layer in lead will vary depending on radionuclide that is being shielded. Half-value layers can be obtained from radiopharmaceutical package inserts. For example, the half-value layer of 99mTc (the most commonly used radionuclide in nuclear medicine) is 0.2 mm of lead. 0.95 mm lead will attenuate 90% of the gamma rays, while 1.8 mm of lead will attenuate 99% of the gamma rays. Typically, commercially available syringe shields contain more lead than listed above, therefore, providing adequate protection for the user.

The amount of exposure can be calculated outside the syringe shield based on the syringe shield thickness, the amount of activity in the syringe, and the gamma ray constant for the radionuclide; however, it is much easier to measure the dose rate outside the shield with the syringe in the shield. This will also allow the user to observe that the dose rates are much higher at the ends of the shield, where there is no way to shield the radiopharmaceutical dosage.
Ken "Duke" Lovins, CHP
 

Answer posted on 30 August 2005. The information and material posted on this website is intended as general reference information only. Specific facts and circumstances may alter the concepts and applications of materials and information described herein. The information provided is not a substitute for professional advice and should not be relied upon in the absence of such professional advice specific to whatever facts and circumstances are presented in any given situation. Answers are correct at the time they are posted on the Website. Be advised that over time, some requirements could change, new data could be made available, or Internet links could change. For answers that have been posted for several months or longer, please check the current status of the posted information prior to using the responses for specific applications.
image
image
Home Affiliates Ask the Experts Radiation Terms Employment Meetings